NO970553D0 - Östradiolinneholdende transdermale terapeutiske systemer omfattende hydrofile tilsetningsstoffer - Google Patents

Östradiolinneholdende transdermale terapeutiske systemer omfattende hydrofile tilsetningsstoffer

Info

Publication number
NO970553D0
NO970553D0 NO970553A NO970553A NO970553D0 NO 970553 D0 NO970553 D0 NO 970553D0 NO 970553 A NO970553 A NO 970553A NO 970553 A NO970553 A NO 970553A NO 970553 D0 NO970553 D0 NO 970553D0
Authority
NO
Norway
Prior art keywords
transdermal therapeutic
ostradiol
therapeutic systems
hydrophilic additives
containing transdermal
Prior art date
Application number
NO970553A
Other languages
English (en)
Norwegian (no)
Other versions
NO970553L (no
Inventor
Michael Horstmann
Walter Mueller
Hanshermann Franke
Thomas Pontzen
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of NO970553D0 publication Critical patent/NO970553D0/no
Publication of NO970553L publication Critical patent/NO970553L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO970553A 1994-08-20 1997-02-06 Östradiolinneholdende transdermale terapeutiske systemer omfattende hydrofile tilsetningsstoffer NO970553L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4429664A DE4429664C2 (de) 1994-08-20 1994-08-20 Estradiol-TTS mit wasserbindenden Zusätzen und Verfahren zu seiner Herstellung
PCT/EP1995/003202 WO1996005815A1 (de) 1994-08-20 1995-08-12 Estradiol-tts mit wasserbindenden zusätzen

Publications (2)

Publication Number Publication Date
NO970553D0 true NO970553D0 (no) 1997-02-06
NO970553L NO970553L (no) 1997-02-06

Family

ID=6526229

Family Applications (1)

Application Number Title Priority Date Filing Date
NO970553A NO970553L (no) 1994-08-20 1997-02-06 Östradiolinneholdende transdermale terapeutiske systemer omfattende hydrofile tilsetningsstoffer

Country Status (21)

Country Link
EP (1) EP0776197B1 (xx)
JP (1) JPH10504314A (xx)
KR (1) KR100374476B1 (xx)
CN (1) CN1073413C (xx)
AT (1) ATE173163T1 (xx)
AU (1) AU700119B2 (xx)
CA (1) CA2197865C (xx)
CZ (1) CZ50897A3 (xx)
DE (2) DE4429664C2 (xx)
DK (1) DK0776197T3 (xx)
ES (1) ES2126308T3 (xx)
FI (1) FI118721B (xx)
HU (1) HUT77093A (xx)
IL (1) IL114948A (xx)
NO (1) NO970553L (xx)
NZ (1) NZ291449A (xx)
PL (1) PL180943B1 (xx)
SI (1) SI0776197T1 (xx)
SK (1) SK280299B6 (xx)
WO (1) WO1996005815A1 (xx)
ZA (1) ZA956926B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6623763B2 (en) 1996-01-08 2003-09-23 Lts Lohmann Therape-System Ag Pharmaceutical preparation adhering to the skin, in particular a transdermal therapeutic system for the release of 17-β-estradiol to the human organism
DE19600347A1 (de) * 1996-01-08 1997-07-10 Lohmann Therapie Syst Lts Hauthaftende pharmazeutische Zubereitung, insbesondere TTS zur Abgabe von 17-beta-Estradiol an den menschlichen Organismus
GB9720470D0 (en) 1997-09-25 1997-11-26 Ethical Pharmaceuticals South Inhibition of crystallization in transdermal devices
DE19827732A1 (de) * 1998-06-22 1999-12-23 Rottapharm Bv Transdermales System vom Matrix-Typ zur Abgabe von Wirkstoffen mit einer hohen Abgaberate von Steroid-Hormonen und die Verwendung eines derartigen Systems zur Hormonersatztherapie

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6712090A (en) * 1989-10-13 1991-05-16 Watson Laboratories, Inc. Drug delivery systems and matrix therefor
DE4223360C1 (xx) * 1992-07-16 1993-04-08 Lts Lohmann Therapie-Systeme Gmbh & Co Kg, 5450 Neuwied, De
DE4237453C1 (xx) * 1992-11-06 1993-08-19 Lts Lohmann Therapie-Systeme Gmbh & Co Kg, 5450 Neuwied, De
DE4309830C1 (de) * 1993-03-26 1994-05-05 Lohmann Therapie Syst Lts Wirkstoffpflaster für die Abgabe von Estradiol an die Haut

Also Published As

Publication number Publication date
SK280299B6 (sk) 1999-11-08
CA2197865C (en) 2005-10-25
KR970705380A (ko) 1997-10-09
SI0776197T1 (en) 1999-04-30
KR100374476B1 (ko) 2003-04-23
MX9701301A (es) 1998-05-31
IL114948A (en) 2000-10-31
WO1996005815A1 (de) 1996-02-29
ES2126308T3 (es) 1999-03-16
IL114948A0 (en) 1995-12-08
CZ50897A3 (en) 1997-06-11
ATE173163T1 (de) 1998-11-15
PL180943B1 (pl) 2001-05-31
AU3258395A (en) 1996-03-14
SK21997A3 (en) 1997-07-09
AU700119B2 (en) 1998-12-24
CN1155836A (zh) 1997-07-30
DE59504233D1 (de) 1998-12-17
DK0776197T3 (da) 1999-07-26
DE4429664C2 (de) 1997-09-11
CN1073413C (zh) 2001-10-24
EP0776197B1 (de) 1998-11-11
FI970702A (fi) 1997-02-19
PL319014A1 (en) 1997-07-21
EP0776197A1 (de) 1997-06-04
HUT77093A (hu) 1998-03-02
DE4429664A1 (de) 1996-02-22
ZA956926B (en) 1996-03-25
NO970553L (no) 1997-02-06
CA2197865A1 (en) 1996-02-29
FI118721B (fi) 2008-02-29
NZ291449A (en) 1998-09-24
FI970702A0 (fi) 1997-02-19
JPH10504314A (ja) 1998-04-28

Similar Documents

Publication Publication Date Title
PT93191A (pt) Sistema terapeutico para a administracao retardada e controlada transdermica ou transmucosica de substancias activas
ATE244003T1 (de) Transdermales therapeutisches system
MY111126A (en) Transdermal therapeutic system comprising the active substance acetylsalicylic acid.
WO1997004818A3 (de) Transdermales therapeutisches system zur abgabe von wirkstoffen über die haut an den menschlichen körper
MY103355A (en) Active substance-containing plaster of the controlled administration of active substances to the skin, the use thereof and a process for the controlled administration of active substances to the skin
MY111688A (en) Transdermal therapeutic system comprising the active substance 17-b-estradiol (anhydous)
NO970553D0 (no) Östradiolinneholdende transdermale terapeutiske systemer omfattende hydrofile tilsetningsstoffer
MX9701302A (es) Sistema terapeutico transdermico de estradiol que comprende aditivos higroscopicos.
GR3032219T3 (en) Surface-stabilised pharmaceutical preparation for application on the skin
DE59509643D1 (de) Transdermales therapeutisches system mit hydrolyseschutz
CA2197867A1 (en) Oestradiol transdermal therapeutic system comprising hygroscopic additives
CA2198092A1 (en) Transdermal therapeutic system with protection against hydrolysis
CA2172401A1 (en) Transdermal therapeutic system with acetylsalicylic acid as active substance

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application